i-Seq Biotechnology Selected for INCATE Stage I Support to Advance its Universal Pneumococcal Vaccine
i-Seq Biotechnology, a life science company focused on advancing novel, broad-spectrum vaccines and therapeutics against infectious disease pathogens, announced today that it has signed a Stage I support agreement with...

